Cassidy Blundell

Cassidy Blundell, PhD is a Partner at Mission BioCapital based in Cambridge, MA. At Mission BioCapital, she focuses on investments in early-stage biotechnology companies as well as company creation with interim operational roles at MBC portfolio companies. She is a Board Director at Volnay Therapeutics and ARase Therapeutics and a Board Observer at Mediar Therapeutics.

Before joining the firm as an analyst in 2018, Cassidy completed her graduate studies at the University of Pennsylvania in the HHMI Interfaces program. Cassidy holds a PhD in Bioengineering from the University of Pennsylvania and a B.S. in Biomedical Engineering from Boston University, where she was a member of the Tau Beta Pi Honor Society.

​